High Flow Nasal Cannula Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031

High Flow Nasal Cannula Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Air Oxygen Blender, Nasal Cannula, Heated Inspiratory Circuit, and Active Humidifier); Application (Bronchiectasis, Acute Respiratory Failure, Acute Heart Failure, and Chronic Obstructive Pulmonary Disease); End User (Ambulatory Care Centers, Hospitals and Long-Term Care Centers) and Geography

  • Report Code : TIPMD00002292
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

The high-flow nasal cannula market size is projected to reach US$ 18.5 billion by 2031 from US$ 7.2 billion in 2023. The market is expected to register a CAGR of 12.5% during 2023–2031. The growing incidence of astama and COPD across the globe, the rising geriatric population, and the growth of medical science in emerging nations are likely to remain key trends in the market.

High Flow Nasal Cannula Market Analysis

The number of cases of asthma and COPD has been growing all over the world at a substantial rate. In recent years, the number of smokers and the levels of air pollution in developed and developing countries have been increasing across the globe. Asthma is a medical condition where the airways swell and narrow and also produces mucus. This further leads to wheezing, coughing, and recurrent attacks of breathlessness, which differ in severity and frequency from person to person.  According to the World Health Organization estimates, there are approximately 235 million people suffering from asthma around the world. Moreover, the Centers for Disease Control and Prevention (CDC) reported, approximately19 million adults in the United States (18 years of age or above) are currently suffering from asthma, which accounts for almost 7.7% of the total adult population. Whereas about 6.2 million patients below 18 years of age have asthma, which accounts for 8.4% of the total children population.

High Flow Nasal Cannula Market Overview

The key factors that are driving the growth of the market are rising incidences if asthma and COPD across the globe and the rising geriatric population. However, the side effects associated with the use of high-flow nasal cannula is expected to hamper the growth of the market. The high-flow nasal cannula market is estimated to have a larger share in the United States. The growth of the high-flow nasal cannula market in the United States is expected to grow due to the rise in the cases of respiratory disorders, coupled with the presence of market players offering innovative solutions in the market.  Fisher & Paykel Healthcare Limited and ResMed are among the players holding a significant share of the global high-flow nasal cannula market. For instance, in March 2019, ResMed acquired HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

High Flow Nasal Cannula Market: Strategic Insights

High Flow Nasal Cannula Market

  • CAGR (2023 - 2031)
    12.5%
  • Market Size 2023
    US$ 7.2 Billion
  • Market Size 2031
    US$ 18.5 Billion

Market Dynamics

GROWTH DRIVERS
  • Growing Applications of High Flow Nasal Cannula in Healthcare to Drive High Flow Nasal Cannula Market Growth
FUTURE TRENDS
  • Growing Geriatric Population
OPPORTUNITIES
  • Emerging Market of Asia Pacific

Key Players

  • Fisher & Paykel Healthcare Limited.
  • ResMed ;
  • Great Group Medical Co., Ltd. ;
  • Salter Labs ;
  • TNI Medical Ag ;
  • Mek-Ics Co., Ltd. ;
  • Flexicare Medical Limited ;
  • Vapotherm ;
  • Teleflex Incorporated ;
  • Hamilton Medical

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Component
  • Air Oxygen Blender
  • Nasal Cannula
  • Heated Inspiratory Circuit
  • Active Humidifier
Application
  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease
End User
  • Ambulatory Care Centers
  • Hospital
  • Long-Term Care Centers
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

High Flow Nasal Cannula Market Drivers and Opportunities

Increasing Risk of COPD in Geriatric Population to Favor Market

COPD and asthma are senescence condition which leads to gradual complications. Asthma in older adults is a critical condition that often goes unnoticed, as per the Asthma and Allergy Foundation of America (AAFA). According to the Office of Disease Prevention and Health Promotion (ODPHP), approximately 23 million people in the U.S. have some form of asthma, most of which include the older population. Older people with asthma often need high doses of medication in spite of mild asthma attacks. Hence, they are more likely to suffer from respiratory failure much faster as compared to the younger population. Also, COPD can appear at any age. However, it is more prevalent in the older population and can be fatal. The aging population is growing exponentially worldwide.

Penetration of Advanced Medical Service in Emerging Nation to Favor Market

The growing healthcare industry in developing countries in the Asia Pacific region is creating better opportunities for significant market players to expand their businesses. This is a major reason for the market growth in the forecast period. Most of the major players focus on emerging markets such as India, China, and others as they have a large number of patients suffering respiratory disorders and growing medical tourism in developing countries. Many of the emerging countries are preferred locations for medical tourism. According to the global burden of disease data, India has 18 % of the world’s population, but it has 32% of the global burden of respiratory diseases of the global nasal flow cannula market share.

High Flow Nasal Cannula Market Report Segmentation Analysis

Key segments that contributed to the derivation of the high-flow nasal cannula market analysis are products & services, applications, and end users.

  • Based on Products & Services, the high-flow nasal cannula market is divided into services, consumables, and software. The services segment held a larger market share in 2023.
  • The market is segmented by application into research & development activities, diagnostics, therapeutics, and others. The research & development activities segment held the largest share of the market in 2023.
  • In terms of end users, the market is segmented into academic & research institutes, biotech & pharmaceutical companies, diagnostic laboratories, and others. The academic & research institutes segment held a significant share of the market in 2023.

High Flow Nasal Cannula Market Share Analysis by Geography

The geographic scope of the high flow nasal cannula market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.  North America has largest market share of the high-flow nasal cannula market, by geography. Factors such as prevalence of respiratory disorders and the presence of promising government plans for the development of the care being provided to the patients for respiratory problems such as COPD and asthma. In the US, asthma and chronic obstructive pulmonary disease (COPD) are the substantial public health burdens. Governments are therefore taking initiative and creating patient-centric national guidelines for COPD that are accessible and easy for healthcare professionals to follow. For instance, with existing COPD guidelines, available from the American Thoracic Society (ATS) and the global initiative for Chronic Lung Disease (GOLD), create clinical practice guidelines that set reliable national standards for identifying people at risk for COPD as well as diagnosing and treating people with COPD across the care continuum. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

High Flow Nasal Cannula Market Report Scope

Report Attribute Details
Market size in 2023 US$ 7.2 Billion
Market Size by 2031 US$ 18.5 Billion
Global CAGR (2023 - 2031) 12.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Component
  • Air Oxygen Blender
  • Nasal Cannula
  • Heated Inspiratory Circuit
  • Active Humidifier
By Application
  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease
By End User
  • Ambulatory Care Centers
  • Hospital
  • Long-Term Care Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Fisher & Paykel Healthcare Limited.
  • ResMed ;
  • Great Group Medical Co., Ltd. ;
  • Salter Labs ;
  • TNI Medical Ag ;
  • Mek-Ics Co., Ltd. ;
  • Flexicare Medical Limited ;
  • Vapotherm ;
  • Teleflex Incorporated ;
  • Hamilton Medical
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    High Flow Nasal Cannula Market News and Recent Developments

    The high flow nasal cannula market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the high flow nasal cannula market are listed below:

    • Masimo announced the U.S. introduction of softFlow, innovative pulmonary care therapy which provides nasal high-flow warmed and humidified respiratory gases to spontaneously breathing patients. (Source: Masimo, Press Release, April 2021)
    • Fisher & Paykel Healthcare Corporation Limited announced that it has released the Airvo 3 high flow system. This device incorporates the company’s OptiO2™ closed-loop system for targeted oxygen delivery, which helps to ensure the patient is provided the right level of oxygen. Other new features include an integrated battery, a large touchscreen interface, expanded settings for pediatric and neonatal patients, and an increased maximum flow rate of 70 litres per minute compared to 60 litres per minute on the Airvo 2. (Source: Fisher & Paykel Healthcare Limited, Press Release, May 2022)

    High Flow Nasal Cannula Market Report Coverage and Deliverables

    The “High Flow Nasal Cannula Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • High Flow Nasal Cannula market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • High Flow Nasal Cannula market trends, as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • High Flow Nasal Cannula market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the High Flow Nasal Cannula market
    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Component ; Application ; End User and Geography

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

    Frequently Asked Questions


    Which region dominated the High Flow Nasal Cannula market in 2023?

    Based on geography, the high flow nasal cannula market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global high flow nasal cannula market. Asia Pacific is expected to register the highest CAGR in the high flow nasal cannula market during 2023–2031

    What are the driving factors impacting the High Flow Nasal Cannula market?

    Growing incidences of asthma and COPD across the globe, growing geriatric population largely drive the high flow nasal cannula market size

    Which are the leading players operating in the High Flow Nasal Cannula market?

    The High Flow Nasal Cannula market majorly consists of the players such Allied Healthcare Products Inc.,Teleflex Incorporated, Flexicare Medical Ltd., Vapotherm Inc., ResMed Inc., Fairmont Medical, Fisher & Paykel Healthcare Limited, Well Lead Medical Co. Ltd., and Salter Labs.

    What would be the estimated value of the High Flow Nasal Cannula market by 2031?

    The high flow nasal cannula market size is projected to reach US$ 18.5 billion by 2031

    What is the expected CAGR of the High Flow Nasal Cannula market?

    The market is expected to register a CAGR of 12.5% during 2023–2031

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to High Flow Nasal Cannula Market


    -->